| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.28 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |